| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 35.553 | 44.266 | 44.958 | 45.028 | 58.657 | 37.689 | 36.835 | 44.511 | 41.080 |
| Total Income - EUR | 0 | 36.012 | 44.411 | 44.980 | 45.036 | 58.664 | 37.690 | 36.835 | 44.511 | 41.081 |
| Total Expenses - EUR | 449 | 35.090 | 44.947 | 45.437 | 45.746 | 55.401 | 38.861 | 38.827 | 43.901 | 41.533 |
| Gross Profit/Loss - EUR | -449 | 922 | -535 | -458 | -710 | 3.264 | -1.172 | -1.991 | 610 | -452 |
| Net Profit/Loss - EUR | -449 | 56 | -1.188 | -907 | -1.160 | 2.724 | -1.549 | -2.360 | 164 | -863 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Crismed Parafarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 116 | 128 | 9.806 | 7.550 | 4.837 | 2.748 | 734 | 104 | 104 | 103 |
| Current Assets | 811 | 9.733 | 12.551 | 12.927 | 15.496 | 40.842 | 46.529 | 29.516 | 23.493 | 23.322 |
| Inventories | 0 | 7.232 | 7.724 | 6.229 | 7.192 | 23.323 | 27.662 | 12.885 | 13.012 | 13.479 |
| Receivables | 37 | 1.077 | 1.565 | 2.763 | 3.009 | 4.275 | 2.223 | 1.411 | 910 | 1.471 |
| Cash | 773 | 1.425 | 3.263 | 3.935 | 5.295 | 13.244 | 16.643 | 15.221 | 9.570 | 8.372 |
| Shareholders Funds | -404 | -344 | -1.526 | -2.405 | -3.519 | -728 | -2.260 | -4.627 | -4.449 | -5.287 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.331 | 10.205 | 23.883 | 22.883 | 23.852 | 44.317 | 49.523 | 34.248 | 28.045 | 28.712 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Crismed Parafarm Srl